Related Experiment Video

Updated: Aug 23, 2026

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
06:31

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis

A Fahlgren1, S Hammarstrom, A Danielsson

  • 1Department of Clinical Microbiology and Immunology, Umeå University, Umeå, Sweden.

Clinical and Experimental Immunology
|July 24, 2004
PubMed

Insights

Human beta-defensins (hBD-3 and hBD-4) mRNA expression increases in ulcerative colitis colon epithelium. Crohn

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • Human beta-defensins (hBDs) are antimicrobial peptides crucial for innate immunity.
  • Their role in chronic intestinal inflammation, specifically ulcerative colitis (UC) and Crohn's disease (CD), requires further elucidation.
  • Understanding hBD-3 and hBD-4 expression in intestinal epithelium is key to inflammatory bowel disease (IBD) pathogenesis.

Purpose of the Study:

  • To investigate mRNA expression of hBD-3 and hBD-4 in normal and inflamed human intestinal epithelium.
  • To determine the impact of chronic inflammation in UC and CD on hBD-3 and hBD-4 expression.
  • To examine the effect of pro-inflammatory cytokines on hBD-3 and hBD-4 mRNA levels in colon cells.

Main Methods:

  • Real-time quantitative reverse transcription-polymerase chain reaction (QRT-PCR) for mRNA quantification.
  • In situ hybridization for localized mRNA expression analysis in intestinal tissues.
  • Analysis of intestinal specimens from UC, CD patients, and healthy controls; cytokine stimulation assays.

Main Results:

  • Normal small and large intestinal epithelial cells express both hBD-3 and hBD-4 mRNA, with higher hBD-3 levels.
  • mRNA expression is higher in intestinal crypts than villi/luminal compartments.
  • Interferon-gamma significantly increased hBD-3 mRNA expression, but not hBD-4.
  • Colonic epithelial cells in UC patients showed significantly increased hBD-3 and hBD-4 mRNA compared to controls.
  • CD patients' small intestinal epithelial cells did not exhibit increased expression; Crohn's colitis showed no significant hBD-4 increase.

Conclusions:

  • Chronic inflammation in UC significantly enhances hBD-3 and hBD-4 mRNA expression in colonic epithelium.
  • The impact of inflammation on hBD expression in Crohn's disease is less pronounced and site-specific.
  • hBD-3 and hBD-4 represent potential therapeutic targets or biomarkers in inflammatory bowel disease.

More Related Videos

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance07:32

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance

Published on: December 3, 2020

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...